Enter Modius: Neurovalens's innovative new solution to insomnia

Author:

Iskander Andrew

Abstract

Adequate sleep is an important aspect of a healthy lifestyle that increasingly seems to evade many. Factors like elevated stress and poor sleep hygiene are some of the primary culprits behind this, and the consequences they can have on patients’ health are hard to overstate. Insufficient sleep has been documented to have adverse long-term effects on patients’ cardiovascular health, immune systems, and mental well-being, among many other facets of health. Given this, patients with insomnia are at significantly elevated risk of developing these negative health outcomes over time. Insomnia is defined as difficulty with sleep onset or maintenance with associated daytime deficiencies, such as poor concentration. In Ireland, it has been estimated that up to 15% of the population struggle with this potentially debilitating disorder, surpassing some other European populations. Further complicating things, the management of this disorder can be quite difficult and inconsistent. The pharmacological options we currently have at our disposal tend to either have limited efficacy, like melatonin receptor agonists, or carry the risk of dependence, such as benzodiazepines. As for non-pharmacological therapies, our options are extremely lacking, with cognitive behavioural therapy being the only such treatment currently recommended by the Centers for Disease Control and Prevention (CDC).

Publisher

University College Cork

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3